MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.
Alcon C, Martín F, Prada E, Mora J, Soriano A, Guillén G, Gallego S, Roma J, Samitier J, Villanueva A, Montero J.
Alcon C, et al. Among authors: mora j.
Cell Death Discov. 2022 Apr 7;8(1):172. doi: 10.1038/s41420-022-00959-w.
Cell Death Discov. 2022.
PMID: 35393436
Free PMC article.